Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Carebot AI MMG Medical Device for Detection and Radiographic Assessment of Breast Lesions and Quantitative Analysis of Breast Density: A Multicentric, Multi-Reader Study

NCT06428799 is registered in ClinicalTrials.gov with Carebot s.r.o. as lead sponsor.

NCT NCT06428799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06428799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Carebot AI MMG Medical Device for Detection and Radiographic Assessment of Breast Lesions and Quantitative Analysis of Breast Density: A Multicentric, Multi-Reader Study
Lead sponsor
Carebot s.r.o.
Phase
Observational
Overall status
Completed
Start date
January 14, 2022
Completion date
April 24, 2024
Enrollment
122 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast tumor benign